The drug, developed by Paris-based Sanofi and Tarrytown, N.Y.-based Regeneron Therapeutics, could earn approval by next March, reports Reuters.
The priority review process, which expedites the review of a drug application to about six months after filing, was created to decrease the time it takes to put new medicines on the market.
More articles on supply chain:
Mylan working on EpiPen formulation with longer shelf life
FDA fast tracks malaria vaccine
Intermountain Healthcare recognizes 4 suppliers for outstanding work
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
